| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.15 | 0.0003 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.19 | 0.0003 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0006 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.16 | 0.0007 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.17 | 0.0008 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0009 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |